Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and Immunologic Characteristics of Colorectal Cancer Tumors Expressing LY6G6D.

International journal of molecular sciences - 14 May 2024

Sanvicente García Adrián, Pedregal Manuel, Paniagua-Herranz Lucía, Díaz-Tejeiro Cristina, Nieto-Jiménez Cristina, Pérez Segura Pedro, Munkácsy Gyöngyi, Győrffy Balázs, Calvo Emiliano, Moreno Víctor, Ocaña Alberto

Abstract excerpt

The identification of targets that are expressed on the cell membrane is a main goal in cancer research. The Lymphocyte Antigen 6 Family Member G6D (LY6G6D) gene codes for a protein that is mainly present on the surface of colorectal cancer (CRC) cells. Therapeutic strategies against this protein like the development of T cell engagers (TCE) are currently in the early clinical stage. In the present work, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenomatous Polyposis Coli Protein
Share to Antigens, Ly

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Colorectal Neoplasms

Share to Gene Expression Regulation, Neoplastic

Share to GPI-Linked Proteins

Share to Tumor Microenvironment

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 38791382
DOI: 10.3390/ijms25105345
PMCID: PMC11121234

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and Immunologic Characteristics of Colorectal Cancer Tumors Expressing LY6G6D.PMID 38791382Read ↗

LY6G6D is Epigenetically Activated in Classical Colorectal Adenocarcinoma and Hyper-Methylated in Mucinous Subtypes Determining Resistance to FOLFOX Therapeutic Regimens.Semantic proximity Read ↗

Lymphocyte antigen 6G6D-mediated modulation through p38α MAPK and DNA methylation in colorectal cancerSemantic proximity Read ↗

JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancerSemantic proximity Read ↗

The bioinformatics and experimental analysis of CD276 for prognosis and immune infiltrates in colon adenocarcinomaSemantic proximity Read ↗

Decreased m6A Modification of CD34/CD276(B7-H3) Leads to Immune Escape in Colon CancerSemantic proximity Read ↗

Novel Anti-LY6G6D/CD3 T-Cell–Dependent Bispecific Antibody for the Treatment of Colorectal CancerSemantic proximity Read ↗

IGSF6 is a novel biomarker to evaluate immune infiltration in mismatch repair-proficient colorectal cancerSemantic proximity Read ↗

Interleukin-6 as a Pan-Cancer Prognostic Inflammatory Biomarker: A Population-Based Study and Comprehensive Bioinformatics AnalysisSemantic proximity Read ↗

The Role of SRMS in Colorectal Cancer by Bioinformatics AnalysisSemantic proximity Read ↗

Integrative multi-omics analysis identified FUT9 and MS4A3 as novel immune-phenotype and prognosis biomarkers for colorectal cancer and analyze the role of FUT9 in oncoimmunology.Semantic proximity Read ↗

Predictors of response to immunotherapy in colorectal cancerSemantic proximity Read ↗

Identification and Validation of m6A-GPI Signatures as a Novel prognostic Model for Colorectal CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.